Serum adiponectin and leptin levels in psoriatic patients according to topical treatment

Abstract

Objectives: Psoriasis has been considered as a systemic disease associated with obesity, cardiovascular diseases and metabolic syndrome. Adipokines have influence on many metabolic processes. Aim of this study was to evaluate the effect of conventional topical treatment on serum adiponectin and leptin levels in patients with psoriasis.

Methods: Forty-nine patients with relapse of plaque-type psoriasis and 16 healthy controls were examined. Blood samples were collected before therapy and after 14 days of application. Serum adiponectin and leptin concentrations were examined by enzyme-linked immunosorbent assay for correlations with effectiveness of topical treatment.

Results: Adiponectin and leptin serum levels were significantly decreased in psoriatic patients in comparison to the controls. As a result of the topical treatment, serum adiponectin level did not significantly change. Serum leptin level increased significantly, still remaining lower than in the controls.

Conclusions: Leptin might be a useful marker in assessing the efficacy of the treatment for psoriasis.

• Adipokines
• adiponectin
• leptin
• psoriasis
• psoriasis therapy

Declaration of interest

The authors state that they have no financial or other relationships that could lead to conflict of interest with the work presented in the submitted paper.